Moderna is projected to have data to report by the end of November on the company’s Covid-19 vaccine program.
UCB S.A. is flexing the company’s M&A muscles once again with the acquisition of Handl Therapeutics BV, a rapidly growing and transformative gene therapy company based in Leuven, Belgium.
A combination of Canadian drug developer Medicago’s experimental Covid-19 vaccine and a booster from Britain’s GlaxoSmithKline will enter a large study with more than 30,000 volunteers in 2020.
Envision Pharma Group, a leading global technology-enabled scientific communications company, announced the acquisition of Two Labs, an industry-leading provider of integrated and customized commercial solutions to the pharmaceutical and biotechnology sector.
After months of urging the public to wear masks and facial coverings to help stop infected people from spreading Covid-19, the Centers for Disease Control and Prevention (CDC) stated in newly released guidance that masks also protected the mask wearer from being infected.
PharmaLive talked to Conran Design Group Managing Director Christina Falzano about her experiences working with tech companies’ expansion into the health, wellness and pharma spaces in driving changes in the healthcare industry – especially in how they reposition post-COVID.
Ugur Sahin, founder and chief executive officer of Germany-based BioNTech, sees the potent efficacy of BNT162b2 – the vaccine developed by his company and partner Pfizer – as the possible “beginning of the end” of the coronavirus pandemic.
Many brands have yet to catch up to the Web Content Accessibility Guidelines (WCAG), for digital inclusion and accessibility for all users.
Shortages of flu shots this year are not related to drugmakers ramping up production of potential Covid-19 vaccines, the head of vaccines at GlaxoSmithKline (GSK) said.
Amgen and AstraZeneca announced that their Phase III NAVIGATOR trial of the potential first-in-class human monoclonal antibody tezepelumab hit the primary endpoint in severe asthma.
